Charles Schwab’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-489,030
| Closed | -$73.9M | – | 3631 |
|
|
2022
Q3 | $73.9M | Sell |
489,030
-138,023
| -22% | -$20.9M | 0.03% | 557 |
|
|
2022
Q2 | $91.4M | Buy |
627,053
+23,228
| +4% | +$3.38M | 0.03% | 489 |
|
|
2022
Q1 | $71.6M | Buy |
603,825
+38,955
| +7% | +$4.62M | 0.02% | 665 |
|
|
2021
Q4 | $77.8M | Buy |
564,870
+13,271
| +2% | +$1.83M | 0.02% | 646 |
|
|
2021
Q3 | $76.6M | Buy |
551,599
+152,640
| +38% | +$21.2M | 0.03% | 622 |
|
|
2021
Q2 | $38.7M | Buy |
398,959
+30,353
| +8% | +$2.95M | 0.01% | 1059 |
|
|
2021
Q1 | $25.2M | Buy |
368,606
+24,268
| +7% | +$1.66M | 0.01% | 1341 |
|
|
2020
Q4 | $29.5M | Buy |
344,338
+3,043
| +0.9% | +$261K | 0.01% | 1120 |
|
|
2020
Q3 | $22.2M | Buy |
341,295
+24,684
| +8% | +$1.6M | 0.01% | 1136 |
|
|
2020
Q2 | $23.1M | Buy |
316,611
+29,530
| +10% | +$2.16M | 0.01% | 1072 |
|
|
2020
Q1 | $9.77M | Buy |
287,081
+29,697
| +12% | +$1.01M | 0.01% | 1458 |
|
|
2019
Q4 | $14M | Sell |
257,384
-4,869
| -2% | -$265K | 0.01% | 1455 |
|
|
2019
Q3 | $10.9M | Buy |
262,253
+40,389
| +18% | +$1.69M | 0.01% | 1547 |
|
|
2019
Q2 | $9.72M | Buy |
221,864
+27,903
| +14% | +$1.22M | 0.01% | 1604 |
|
|
2019
Q1 | $9.98M | Buy |
193,961
+16,629
| +9% | +$856K | 0.01% | 1588 |
|
|
2018
Q4 | $6.56M | Buy |
177,332
+19,323
| +12% | +$715K | 0.01% | 1732 |
|
|
2018
Q3 | $5.93M | Buy |
158,009
+19,254
| +14% | +$723K | ﹤0.01% | 1955 |
|
|
2018
Q2 | $5.48M | Buy |
138,755
+51,113
| +58% | +$2.02M | ﹤0.01% | 1947 |
|
|
2018
Q1 | $2.26M | Buy |
87,642
+47,505
| +118% | +$1.22M | ﹤0.01% | 2285 |
|
|
2017
Q4 | $1.08M | Buy |
40,137
+1,872
| +5% | +$50.5K | ﹤0.01% | 2485 |
|
|
2017
Q3 | $1.43M | Buy |
38,265
+1,933
| +5% | +$72.3K | ﹤0.01% | 2407 |
|
|
2017
Q2 | $909K | Buy |
+36,332
| New | +$909K | ﹤0.01% | 2486 |
|